The Role of Upadacitinib in Refractory Dermatomyositis: A Systematic Review

Name: The Role of Upadacitinib in Refractory Dermatomyositis: A Systematic Review
Creator: Anagha Srivatsa
Published: 2025-05-14T11:44:40.566Z
Keywords: Dermatology, Dermatomyositis, Janus Kinase

Srivatsa, Anagha; Yaldo, Marissa; Rehman, Rafey; Moossavi, Meena; Potts, Geoffrey; Mehregan, Darius

doi:10.17632/24vtbhd83t.1

The Role of Upadacitinib in Refractory Dermatomyositis: A Systematic Review

Published: 14 May 2025| Version 1 | DOI: 10.17632/24vtbhd83t.1

Contributors:

Anagha Srivatsa, Marissa Yaldo, Rafey Rehman, Meena Moossavi, Geoffrey Potts, Darius Mehregan

Description

Recent reports highlight upadacitinib, a JAK inhibitor that is highly selective for JAK1, as a promising treatment when used off-label for dermatomyositis. This systematic review aims to investigate upadacitinib as a therapy for refractory dermatomyositis.

The Role of Upadacitinib in Refractory Dermatomyositis: A Systematic Review

Description

Files

Categories

Licence